ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, function, and independence in people with spinal cord injury (SCI), today provided a third quarter 2023 business update. “We remain focused on completing activities required to submit an FDA de novo application for clearance of…Read More
ONWARD Reports Q3 Business Update and YearToDate Highlights
